Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
63
VALN Quote, Financials, Valuation and Earnings
Last price:
$10.49
Seasonality move
:
-7.72%
Day range:
$11.00 - $11.31
52-week range:
$5.43 - $12.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.43x
P/B ratio:
5.10x
Volume:
11.8K
Avg. volume:
18.1K
1-year change:
56.26%
Market cap:
$902.2M
Revenue:
$183.4M
EPS (TTM):
-$1.37
Analysts' Opinion
-
Consensus RatingValneva SE has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.10, Valneva SE has an estimated upside of 23.47% from its current price of $11.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.30 representing 21.77% downside risk from its current price of $11.21.
Fair Value
-
According to the consensus of 3 analysts, Valneva SE has 23.47% upside to fair value with a price target of $13.10 per share.
VALN vs. S&P 500
-
Over the past 5 trading days, Valneva SE has overperformed the S&P 500 by 0.32% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Valneva SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Valneva SE revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Valneva SE reported revenues of $34.4M.
Earnings Growth
-
Valneva SE earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Valneva SE reported earnings per share of -$0.60.
Enterprise value:
963.7M
EV / Invested capital:
--
Price / LTM sales:
4.43x
EV / EBIT:
38.30x
EV / Revenue:
4.88x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-23.97x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
38.30x
Gross Profit (TTM):
$88.9M
Return On Assets:
-21.08%
Net Income Margin (TTM):
-57.8%
Return On Equity:
-56.21%
Return On Invested Capital:
-26.5%
Operating Margin:
-137.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $234.8M | $171.9M | $197.4M | $50.3M | $34.4M | |
| Gross Profit | $29.5M | $66.4M | $88.9M | $22.1M | $6.4M | |
| Operating Income | -$142.7M | -$109.3M | -$99.5M | -$23M | -$47.4M | |
| EBITDA | -$106.1M | $23.2M | -- | -- | -$41.1M | |
| Diluted EPS | -$1.74 | -$0.09 | -$1.37 | -$0.13 | -$0.60 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $466.8M | $339.5M | $338.8M | $315.3M | |
| Total Assets | -- | $683.9M | $551.1M | $576.6M | $526.7M | |
| Current Liabilities | -- | $366.6M | $231M | $121.8M | $176.8M | |
| Total Liabilities | -- | $522.3M | $384.3M | $333.9M | $349.9M | |
| Total Equity | -- | $161.6M | $166.8M | $242.7M | $176.8M | |
| Total Debt | -- | $146.1M | $170.1M | $202.9M | $161M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$214.2M | -$170M | -$40.3M | -$15.4M | -$24.7M | |
| Cash From Investing | -$12M | $58.9M | $8.4M | -$17.8M | -$160.7K | |
| Cash From Financing | $135.5M | $97.5M | -$11M | $36.3M | -$300K | |
| Free Cash Flow | -$229.9M | -$198M | -$40.2M | -$32.6M | -$25.6M | |
VALN
Sector
Market Cap
$902.2M
$25.1M
Price % of 52-Week High
86.61%
48.72%
Dividend Yield
0%
0%
Shareholder Yield
-2.94%
-1.6%
1-Year Price Total Return
56.26%
-18.38%
Beta (5-Year)
--
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$10.86
200-day SMA
Buy
Level
$8.85
Bollinger Bands (100)
Buy
Level
8.65 - 10.37
Chaikin Money Flow
Buy
Level
6.3M
20-day SMA
Buy
Level
$10.83
Relative Strength Index (RSI14)
Buy
Level
56.71
ADX Line
Buy
Level
16.02
Williams %R
Neutral
Level
-72.0183
50-day SMA
Buy
Level
$10.05
MACD (12, 26)
Buy
Level
0.30
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
6.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.8074)
Sell
CA Score
(Annual)
Level (-2.097)
Sell
Beneish M-Score
(Annual)
Level (-2.0057)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (5.1682)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.
Stock Forecast FAQ
In the current month, VALN has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VALN average analyst price target in the past 3 months is $13.10.
-
Where Will Valneva SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Valneva SE share price will rise to $13.10 per share over the next 12 months.
-
What Do Analysts Say About Valneva SE?
Analysts are divided on their view about Valneva SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Valneva SE is a Sell and believe this share price will drop from its current level to $8.30.
-
What Is Valneva SE's Price Target?
The price target for Valneva SE over the next 1-year time period is forecast to be $13.10 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is VALN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Valneva SE is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VALN?
You can purchase shares of Valneva SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Valneva SE shares.
-
What Is The Valneva SE Share Price Today?
Valneva SE was last trading at $10.49 per share. This represents the most recent stock quote for Valneva SE. Yesterday, Valneva SE closed at $11.21 per share.
-
How To Buy Valneva SE Stock Online?
In order to purchase Valneva SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get VALN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VALN
Sector
P/E ratio
--
21.37x
PEG ratio
-0.01x
-0.01x
P/B ratio
5.10x
1.73x
Price / LTM sales
4.43x
1.46x
Growth Metrics
VALN
Sector
Revenue growth
-31.73%
3.27%
Earnings growth
-382.49%
12.13%
Revenue (5-year growth)
5.37%
6.25%
Earnings forecast
-$0.10
-$0.20
Profitability
VALN
Sector
Profitability FY 2024
$68.8M
$2.3M
Return on invested capital
-26.5%
-33.43%
Return on assets
-21.08%
-29.94%
Return on equity
-56.21%
-40.07%
Earnings Date
Last Earnings Date
Aug
12
Next Earnings Date
Mar
18
Estimated Next Earnings Date
Nov
11
Balance Sheet
VALN
Sector
Total cash
$168.6M
$24.9M
Short term investments
--
$23M
Total assets
$527.9M
$70.1M
Long term debt
$161M
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
ORKA alert for Mar 14
Oruka Therapeutics, Inc. [ORKA] is up 16.04% over the past day.
Buy
92
APEI alert for Mar 14
American Public Education, Inc. [APEI] is up 26.24% over the past day.
Sell
37
GDXD alert for Mar 14
MicroSectors Gold Miners -3X Inverse Leveraged ETN [GDXD] is up 26.02% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
